Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/β-Catenin Signaling PathwayMengyu Sun, Jing Xu, Jingwan Wu et al.|Marine Drugs|2022Cited by 13